Visual Analytics Dashboard

Interactive charts and insights from clinical trials, publications, and market data

Updated: Just now
↑ 23%
Clinical Trial Activity
vs. last month
4,521
Active Trials
Phase 2-3
892
New Publications
This week
↓ 5%
Patent Filings
vs. last month
Clinical Trials by Phase
1,245
Phase 1
1,890
Phase 2
2,340
Phase 2/3
1,567
Phase 3
890
Phase 4
By Therapeutic Area
7,932
Total
Oncology 35%
Immunology 25%
Neurology 20%
Cardiology 10%
Other 10%
Publication Trends (12 months)
Feb 2025 May 2025 Aug 2025 Nov 2025 Feb 2026
Geographic Distribution of Trials
High activity
Low activity
2,145
N. America
1,890
Europe
2,567
Asia-Pacific
456
Latin America
Top Trial Sponsors
1. Pfizer 234 trials
2. Novartis 198 trials
3. Roche 187 trials
4. Merck 165 trials
5. AstraZeneca 154 trials
6. Johnson & Johnson 143 trials
7. Bristol-Myers Squibb 132 trials
Trending Research Topics
GLP-1 Agonists CAR-T Therapy Alzheimer's mRNA Vaccines Gene Editing ADCs Bispecifics NASH/MASH Obesity RSV
Based on publication frequency and trial activity in the last 90 days
Your Recent Queries
PCSK9 inhibitors pipeline 2h ago
Metformin repurposing oncology 5h ago
NASH clinical trials phase 3 1d ago
Ozempic adverse events 2d ago
Bispecific antibodies market 3d ago